InvestorsHub Logo
Followers 0
Posts 64
Boards Moderated 0
Alias Born 11/28/2012

Re: None

Tuesday, 03/31/2020 10:29:14 AM

Tuesday, March 31, 2020 10:29:14 AM

Post# of 429367
IF all legal avenues eventually appeared to be high risk or unavailable.... are there any compliance issues if Amarin chose to serve as contract manufacture 'broker' (since they have source of supplies locked up) to generics for the U.S. market, and ran full throttle under the Amarin brand OUS? It would be a tough call to yield to generics in this way but it could keep them operating worldwide. I've been in the business of private labeling pharmaceuticals for generics successfully in the past. Still looking for some sort of bold action from mgmt if they have the will to act.... hard to say right now.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News